Traditional Chinese Medicine in Management of Childhood Asthma

Phase

Condition

Asthma

Treatment

N/A

Clinical Study ID

NCT03645889

2017/3129

Ages 6-16
All Genders

Study Summary

Bronchial Asthma is a common childhood chronic disease characterized by chronic inflammation of the airways. Frequent relapse of asthma has serious impacts on the child's growth, impairs quality of life (QoL) and mortality, posing a huge economic burden on both family and society. According to Traditional Chinese Medicine (TCM) principles and theory, the main reason for children suffering from asthma are congenital deficiencies at birth which were not corrected and/or lack of appropriate care in the early childhood, leading to insufficiency of the lung, spleen and kidney, resulting in susceptibility to external pathogenic factors. During the interval phase of the illness, wheezing is not prominent and the "Lung-Spleen Qi Deficiency" (LSQD) syndrome is most commonly seen. TCM treatment aims to strengthen the body's immune system by nourishing the spleen, replenishing "Qi"(vital energy), tonifying the lungs and strengthening the exterior, thereby reducing incidences of relapse and improve QoL. It is hypothesized that TCM has adjuvant roles in the management of mild-moderate childhood asthma. Hence the primary aim of this study is to investigate the efficacy of using herbal TCM as adjuvant therapy in the management of symptoms and QoL in asthmatic patients. A randomized, double-blind cross-sectional, 2-arms placebo-controlled study will be carried out. Pediatric patients with mild-moderate asthma identified with LSQD will be randomized to either control or treatment group. Study participants in control group will continue their conventional western medicine (CWM) while those in TCM group will consume a decoction of herbal TCM for 12-weeks in addition to their CWM. Pulmonary function tests, Asthma Control Test, QoL and TCM questionnaires will be used as outcome measurement tools. In addition, liver and kidneys functions will be monitored for signs of toxicity.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Have asthma which is partly controlled based on Global Initiative for Asthma (GINA)asthma control classification guideline and has Asthma Control Test (ACT) score ≥17 atpoint of recruitment.
Currently using fluticasone as the only regular inhaled corticosteroid therapy forasthma control with fluticasone dosage ≤ 250mcg/day for at least past 3 months.
Able to perform pulmonary function test
Fulfil the TCM criteria of "lung-spleen qi deficiency " type of asthma

Exclusion

Exclusion Criteria:

Laboratory results for renal and liver functions outside of normal range.
Concomitant use of theophylline or montelukast.
Concomitantly or in the last 3 months taking TCM
Pregnant or lactation
Known allergic reactions to food such as peanut, seafood, egg and milk

Study Design

October 15, 2018

September 30, 2021

Study Description

It is hypothesized that herbal Traditional Chinese Medicine (TCM) has adjuvant roles in the management of mild-moderate childhood asthma.

The primary aim of the study is to investigate the efficacy of using herbal TCM as adjuvant therapy in the management of symptoms and quality of life in asthmatic patients.

The secondary aim of the study is to investigate the improvement in pulmonary function test (PFT) and fractional exhaled nitric oxide (FeNO) test in asthmatic patients taking herbal TCM adjuvant therapy, and to monitor the safety profile of herbal TCM with regards to renal and liver functions.

Connect with a study center

KK Women's and Children's Hospital
Singapore, 229899
Singapore
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.